دورية أكاديمية
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors
| العنوان: | The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors |
|---|---|
| المؤلفون: | Liguoro, Domenico, Frigerio, Rachele, Ortolano, Arianna, Sacconi, Andrea, Acunzo, Mario, Romano, Giulia, Nigita, Giovanni, Bellei, Barbara, Madonna, Gabriele, Capone, Mariaelena, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro, Fattore, Luigi |
| المساهمون: | Liguoro, Domenico, Frigerio, Rachele, Ortolano, Arianna, Sacconi, Andrea, Acunzo, Mario, Romano, Giulia, Nigita, Giovanni, Bellei, Barbara, Madonna, Gabriele, Capone, Mariaelena, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro, Fattore, Luigi |
| بيانات النشر: | Springer Nature London |
| سنة النشر: | 2024 |
| المجموعة: | Sapienza Università di Roma: CINECA IRIS |
| مصطلحات موضوعية: | melanoma, microRNA, targeted therapies |
| الوصف: | Therapy of melanoma has improved dramatically over the last years thanks to the development of targeted therapies (MAPKi) and immunotherapies. However, drug resistance continues to limit the efficacy of these therapies. Our research group has provided robust evidence as to the involvement of a set of microRNAs in the development of resistance to target therapy in BRAF-mutated melanomas. Among them, a pivotal role is played by the oncosuppressor miR-579-3p. Here we show that miR-579-3p and the microphthalmia-associated transcription factor (MITF) influence reciprocally their expression through positive feedback regulatory loops. In particular we show that miR-579-3p is specifically deregulated in BRAF-mutant melanomas and that its expression levels mirror those of MITF. Luciferase and ChIP studies show that MITF is a positive regulator of miR-579-3p, which is located in the intron 11 of the human gene ZFR (Zink-finger recombinase) and is co-transcribed with its host gene. Moreover, miR-579-3p, by targeting BRAF, is able to stabilize MITF protein thus inducing its own transcription. From biological points of view, early exposure to MAPKi or, alternatively miR-579-3p transfection, induce block of proliferation and trigger senescence programs in BRAF-mutant melanoma cells. Finally, the long-term development of resistance to MAPKi is able to select cells characterized by the loss of both miR-579-3p and MITF and the same down-regulation is also present in patients relapsing after treatments. Altogether these findings suggest that miR-579-3p/MITF interplay potentially governs the balance between proliferation, senescence and resistance to therapies in BRAF-mutant melanomas. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/38472212; volume:15; issue:3; firstpage:1; lastpage:11; numberofpages:11; journal:CELL DEATH & DISEASE; https://hdl.handle.net/11573/1705216Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85187522115 |
| DOI: | 10.1038/s41419-024-06580-2 |
| الإتاحة: | https://doi.org/10.1038/s41419-024-06580-2Test https://hdl.handle.net/11573/1705216Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.1BAB43B0 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1038/s41419-024-06580-2 |
|---|